TrialJournal of medical economics2017

Evaluation of the long-term cost-effectiveness of IDegLira versus liraglutide added to basal insulin for patients with type 2 diabetes failing to achieve glycemic control on basal insulin in the USA.

B Hunt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.